Commercial collaborations and activities are central to our work at NIHR Cambridge Biomedical Research Centre and we are pleased to be working in partnership with a range of public sector and charitable partners.
Their investment in, and support for, our research is enabling us to develop our contribution to research into immunity and infection. Cambridge BRC provided over £1m support to the theme between 2009-2010, and this helped to lever almost £8.5m additional investment from the following organisations:
- Asthma UK www.asthma.org.uk
- NIHR Health Technology Assessment Programme www.hta.ac.uk
- Wellcome Trust www.wellcome.ac.uk
- Equine HealthCare www.equinehealthcare.com
- Addenbrooke's Charitable Trust www.act4addenbrookes.org.uk
- Medical Research Council www.mrc.ac.uk
- GlaxoSmithKline www.gsk.co.uk
Rightnav:
Highlights
Translational medicine and autoimmunity (Smith, Jayne)
The BRC has funded a bio-informatics post to support the biomarker discovery programme run by the Smith laboratory, which has resulted in the discovery of a prognostic biomarker which has been patented, published in Nature Medicine, and is soon to enter clinical trials. In addition to the initial findings made in SLE and vasculitis, these findings have been replicated in Inflammatory Bowel Disease and transplantation.
Read more...
